Stocks and Investing
by (remove) : Raghuram Selvaraju
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Raghuram Selvaraju
RSSJSONXMLCSV
Thu, October 3, 2024
Wed, October 2, 2024
Tue, October 1, 2024
Mon, September 30, 2024
Tue, September 17, 2024
Mon, September 16, 2024
Wed, September 11, 2024
Fri, September 6, 2024
Thu, September 5, 2024
Tue, September 3, 2024
Wed, August 28, 2024
Tue, August 27, 2024
Thu, August 22, 2024
Mon, August 19, 2024
Thu, August 15, 2024
Wed, August 14, 2024

Raghuram Selvaraju Reiterated (URGN) at Strong Buy and Held Target at $60 on, Oct 3rd, 2024


Published on 2024-10-28 14:37:13 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "UroGen Pharma Ltd." (URGN) at Strong Buy and Held Target at $60 on, Oct 3rd, 2024.

Raghuram has made no other calls on URGN in the last 4 months.



There are 3 other peers that have a rating on URGN. Out of the 3 peers that are also analyzing URGN, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Raghuram


  • Kelsey Goodwin of "Guggenheim" Initiated at Strong Buy and Held Target at $40 on, Thursday, August 22nd, 2024
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $40 on, Friday, June 14th, 2024
  • Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $54 on, Friday, June 14th, 2024
Contributing Sources